In a clinical study of forty-two patients, an average abdominal circumference reduction of 2.6 cm was achieved following a single VelaShape III treatment protocol Syneron Medical Ltd. (NASDAQ: ELOS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback